Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”

Informazioni relative al progetto

EvolveBBMRI

ID dell’accordo di sovvenzione: 101131701

DOI

10.3030/101131701

Data della firma CE 3 Novembre 2023

Data di avvio 1 Gennaio 2024

Data di completamento 31 Dicembre 2026

Finanziato da

• Research infrastructures

Costo totale

€ 4 999 943,75

Contributo UE

€ 3 999 955,00

Coordinato da

BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM (BBMRI-ERIC)
Austria

Periodic Reporting for period 1 - EvolveBBMRI (Accelerating datafication for support of EU health priorities, greening of biobanks and integrated approach to “One Health”)

Periodo di rendicontazione: 2024-01-01 al 2025-06-30

Sintesi del contesto e degli obiettivi generali del progetto

The EvolveBBMRI project aims to further develop BBMRI-ERIC for the benefit of its scientific communities and users, increase its capacity to serve EU policy priorities and further deepen its collaboration with industry. It is structured in four thematic pillars: 1) Acceleration of datafication of biobanks and biomolecular resources to enable reproducible advanced medical research in support of EU health priorities ; 2) Teaming with industry towards greener biobanking; 3) Long-term sustainability measures for BBMRI addressing also RI landscape gaps; and 4) Strengthened approach for career paths, training and outreach activities to maximise impact. The overarching goal of the EvolveBBMRI project is to, together with the Member States, further develop BBMRI-ERIC for the benefit of its scientific communities and users, increase its capacity to serve EU policy priorities and further deepen its collaboration with industry.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

The first reporting period of the EvolveBBMRI project spans from 1 January 2024 (M1) to 30 June 2025 (M18). During this period, the project focused on advancing key objectives across its six Work Packages. Eleven deliverables were submitted, and ten milestones were reached (two were postponed to the second reporting period -M21 and M24). The deliverables and milestones were co-created not only with the Member states taking part in the consortium, but with all Member and Observer via discussion and feedback though the BBMRI-ERIC governance bodies (assembly of members, management committee). This will ensure that the implementation of the deliverables will have an overall impact across the infrastructure.

Some of the key deliverables are: Deliverable 1.1 "Concept for Datafication of Biobanks," was successfully developed, laying out the conceptual and technical groundwork for enabling biobanks as data integration centres. The Green Biobanking Gaps and Challenges Survey (D2.1 "Green Biobanking Mapping") gathered responses from 93 biobanks across 18 BBMRI-ERIC National Nodes. Furthermore, Deliverable 3.1 the "Draft 10-Year Strategy of BBMRI-ERIC on the 'One Health' Approach in Biobanking," outlining the strategic focus of BBMRI-ERIC for the next decade is the ground document for BBMRI-ERIC actions in the next years.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

Based on the results from the first reporting period, impact has been generated in multiple areas.

In WP1, a comprehensive concept to transform biobanks into advanced data integration centres was developed (D1.1) leveraging cryptographic solutions for secure, cloud-based data processing. Additionally, a robust provenance mechanism was established (D1.2) ensuring quality, transparency, and traceability of biological materials and associated data in a machine-actionable way, thereby enhancing reproducibility and data trust. By the end of the reporting period, a secure cloud storage infrastructure was also implemented (D1.5).

In WP2, which focuses on advancing green biobanking practices, two workshops and a comprehensive survey were conducted to identify critical barriers, such as reliance on fossil fuels, limited waste management systems, lack of staff training, and insufficient funding. The survey, which gathered responses from 93 biobanks across 18 National Nodes (informing D2.1) lays the foundation for actionable next steps in Reporting Period 2 (RP2).

In WP3, sustainable impact is being fostered through the development of the 10-Year Roadmap (D3.1) which provides a strategic outline for BBMRI-ERIC over the next decade, and through a concept for industry collaborations (D3.2) to be further explored in RP2.

WP4 mapped the educational needs of the BBMRI-ERIC community through a catalogue of training activities (MS16), visualised via a competence matrix (MS17) in preparation for the BBMRI-ERIC Academy. These efforts informed a gap analysis of the training offer for Research Infrastructure staff (MS18).

WP5 has been instrumental in ensuring the scientific and operational coherence of the project through effective coordination, structured data management, and strategic external engagement.

WP6 has ensured the ethical integrity of the EvolveBBMRI project through the appointment of an exernal ethics advisor, providing invaluable recommendations for the continuing activities in RP2.